back to cluster viewer
cluster path 00111110111110100
63 words, 11,243 tokens
freq alpha suffix
Words in frequency order
1 | risks | 10,808
|
2 | dangers | 200
|
3 | subjectivity | 48
|
4 | inconveniences | 29
|
5 | risks/benefits | 22
|
6 | stakes | 17
|
7 | nonlinearities | 11
|
8 | high-responders | 10
|
9 | petiole | 9
|
10 | tb-fm | 5
|
11 | epicenters | 4
|
12 | exceedances | 4
|
13 | nontoxicity | 4
|
14 | restrictiveness | 4
|
15 | tb-ffm | 4
|
16 | underpowering | 4
|
17 | drought-tolerance | 3
|
18 | fetotoxicity | 3
|
19 | triglyzerides | 3
|
20 | 2.04-fold | 2
|
21 | crude-oil | 2
|
22 | disulfiduria | 2
|
23 | health-risks | 2
|
24 | knoop-hardness | 2
|
25 | risk=0.65 | 2
|
26 | sympaticotonia | 2
|
27 | 'first- | 1
|
28 | 'hanyak | 1
|
29 | 'maudsley | 1
|
30 | 1-μl | 1
|
31 | 1:89-1:1162 | 1
|
32 | amidinopenicillins | 1
|
33 | co-analgetics | 1
|
34 | controindications | 1
|
35 | crbsi-incidence | 1
|
36 | cryptolepines | 1
|
37 | demeriting | 1
|
38 | disorders-is | 1
|
39 | five-step-concept | 1
|
40 | ft-icr-ms | 1
|
41 | hardness/softness | 1
|
42 | hypermyotonia | 1
|
43 | hyperproinsulinemia | 1
|
44 | hypersynchronization | 1
|
45 | igfr-1 | 1
|
46 | importin-α/-β | 1
|
47 | inductivism | 1
|
48 | insurance-was | 1
|
49 | lma-supreme™was | 1
|
50 | loci/snps | 1
|
51 | microeukaryotes | 1
|
52 | pathologization | 1
|
53 | pm-emissions | 1
|
54 | polytriacetylenes | 1
|
55 | raphan | 1
|
56 | relicts | 1
|
57 | retranslocations | 1
|
58 | saponin-glycosidases | 1
|
59 | tribulations | 1
|
60 | ttbs | 1
|
61 | xiphidiocercariae | 1
|
62 | δcsmc | 1
|
63 | ‘uroselectivity’ | 1
|
Words in alphabetical order
1 | 'first- | 1
|
2 | 'hanyak | 1
|
3 | 'maudsley | 1
|
4 | 1-μl | 1
|
5 | 1:89-1:1162 | 1
|
6 | 2.04-fold | 2
|
7 | amidinopenicillins | 1
|
8 | co-analgetics | 1
|
9 | controindications | 1
|
10 | crbsi-incidence | 1
|
11 | crude-oil | 2
|
12 | cryptolepines | 1
|
13 | dangers | 200
|
14 | demeriting | 1
|
15 | disorders-is | 1
|
16 | disulfiduria | 2
|
17 | drought-tolerance | 3
|
18 | epicenters | 4
|
19 | exceedances | 4
|
20 | fetotoxicity | 3
|
21 | five-step-concept | 1
|
22 | ft-icr-ms | 1
|
23 | hardness/softness | 1
|
24 | health-risks | 2
|
25 | high-responders | 10
|
26 | hypermyotonia | 1
|
27 | hyperproinsulinemia | 1
|
28 | hypersynchronization | 1
|
29 | igfr-1 | 1
|
30 | importin-α/-β | 1
|
31 | inconveniences | 29
|
32 | inductivism | 1
|
33 | insurance-was | 1
|
34 | knoop-hardness | 2
|
35 | lma-supreme™was | 1
|
36 | loci/snps | 1
|
37 | microeukaryotes | 1
|
38 | nonlinearities | 11
|
39 | nontoxicity | 4
|
40 | pathologization | 1
|
41 | petiole | 9
|
42 | pm-emissions | 1
|
43 | polytriacetylenes | 1
|
44 | raphan | 1
|
45 | relicts | 1
|
46 | restrictiveness | 4
|
47 | retranslocations | 1
|
48 | risk=0.65 | 2
|
49 | risks | 10,808
|
50 | risks/benefits | 22
|
51 | saponin-glycosidases | 1
|
52 | stakes | 17
|
53 | subjectivity | 48
|
54 | sympaticotonia | 2
|
55 | tb-ffm | 4
|
56 | tb-fm | 5
|
57 | tribulations | 1
|
58 | triglyzerides | 3
|
59 | ttbs | 1
|
60 | underpowering | 4
|
61 | xiphidiocercariae | 1
|
62 | δcsmc | 1
|
63 | ‘uroselectivity’ | 1
|
Words in suffix order
1 | 'first- | 1
|
2 | igfr-1 | 1
|
3 | 1:89-1:1162 | 1
|
4 | risk=0.65 | 2
|
5 | hyperproinsulinemia | 1
|
6 | sympaticotonia | 2
|
7 | hypermyotonia | 1
|
8 | disulfiduria | 2
|
9 | δcsmc | 1
|
10 | 2.04-fold | 2
|
11 | xiphidiocercariae | 1
|
12 | drought-tolerance | 3
|
13 | crbsi-incidence | 1
|
14 | petiole | 9
|
15 | underpowering | 4
|
16 | demeriting | 1
|
17 | 'hanyak | 1
|
18 | crude-oil | 2
|
19 | 1-μl | 1
|
20 | tb-fm | 5
|
21 | tb-ffm | 4
|
22 | inductivism | 1
|
23 | raphan | 1
|
24 | pathologization | 1
|
25 | hypersynchronization | 1
|
26 | insurance-was | 1
|
27 | lma-supreme™was | 1
|
28 | ttbs | 1
|
29 | co-analgetics | 1
|
30 | exceedances | 4
|
31 | inconveniences | 29
|
32 | triglyzerides | 3
|
33 | nonlinearities | 11
|
34 | stakes | 17
|
35 | polytriacetylenes | 1
|
36 | cryptolepines | 1
|
37 | saponin-glycosidases | 1
|
38 | microeukaryotes | 1
|
39 | disorders-is | 1
|
40 | risks | 10,808
|
41 | health-risks | 2
|
42 | ft-icr-ms | 1
|
43 | amidinopenicillins | 1
|
44 | pm-emissions | 1
|
45 | controindications | 1
|
46 | retranslocations | 1
|
47 | tribulations | 1
|
48 | loci/snps | 1
|
49 | high-responders | 10
|
50 | dangers | 200
|
51 | epicenters | 4
|
52 | knoop-hardness | 2
|
53 | restrictiveness | 4
|
54 | hardness/softness | 1
|
55 | relicts | 1
|
56 | risks/benefits | 22
|
57 | five-step-concept | 1
|
58 | 'maudsley | 1
|
59 | nontoxicity | 4
|
60 | fetotoxicity | 3
|
61 | subjectivity | 48
|
62 | ‘uroselectivity’ | 1
|
63 | importin-α/-β | 1
|